Shares of Walgreens Boots Alliance (WBA) fell during Tuesday’s trading session following a Justice Department lawsuit alleging the pharmacy knowingly issued millions of prescriptions for illegal drugs to customers, mostly related to opioids.
Catalysts hosts Madison Mills and Seana Smith break down the data, exploring how this legal challenge could affect the pharma’s proposed deal with Sycamore Partners that could take the company private.
To view more expert insights and analysis on the latest market action, see more Catalysts here.
This post was written by Angel Smith
Source link
